MicroRNAs in kidney fibrosis and diabetic nephropathy: Roles on EMT and EndMT

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Srivastava, Swayam Prakash ^a   Koya, Daisuke ^a   Kanasaki, Keizo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 6; CALVASCULIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MICRONA 125B; MICRONA 141; MICRONA 151; MICRONA 194; MICRONA 21; MICRONA 215; MICRONA 216; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 142; MICRORNA 34A; NERVE CELL ADHESION MOLECULE; NESTIN; OSTEOGENIC PROTEIN 1; PROTEIN P53; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TRISTETRAPROLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VIMENTIN;

CELL TRANSFORMATION; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIAL MESENCHYMAL TRANSITION; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY FIBROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; REVIEW; RNA ANALYSIS; RNA DEGRADATION; RNA STRUCTURE; TISSUE REGENERATION; UPREGULATION; WOUND HEALING; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM; FIBROSIS; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETIC NEPHROPATHIES; ENDOTHELIUM; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; KIDNEY; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84884853106     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/125469     Document Type: Review

References (60)

1. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
2. Jiang X., Tsitsiou E., Herrick S. E., MiRNAs and the regulation of fibrosis. FEBS Journal 2010 277 9 2015 2021 10.1111/j.1742-4658.2010.07632.x
3. Wynn T.A., Ramalingam T.R., Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine 2012 18 7 1028 1040
4. Boor P., Ostendorf T., Floege J., Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature Reviews Nephrology 2010 6 11 643 656 2-s2.0-78049369136 10.1038/nrneph.2010.120
5. Kim V. N., MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005 6 5 376 385 2-s2.0-18344369543 10.1038/nrm1644 (Pubitemid 40637855)
6. Han J., Lee Y., Yeom K.-H., The Drosha-DGCR8 complex in primary microRNA processing. Genes and Development 2004 18 24 3016 3027 2-s2.0-10644234841 10.1101/gad.1262504 (Pubitemid 39658171)
7. Gwizdek C., Ossareh-Nazari B., Brownawell A. M., Exportin-5 mediates nuclear export of minihelix-containing RNAs. Journal of Biological Chemistry 2003 278 8 5505 5508 2-s2.0-0037458712 10.1074/jbc.C200668200 (Pubitemid 36800789)
8. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
9. Jiang Q., Wang Y., Hao Y., Juan L., Teng M., Zhang X., Li M., Wang G., Liu Y., miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Research 2009 37 1 D98 D104 2-s2.0-58149179989 10.1093/nar/gkn714
10. He L., He X., Lowe S. W., Hannon G. J., microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nature Reviews Cancer 2007 7 11 819 822 2-s2.0-35548957247 10.1038/nrc2232 (Pubitemid 350006254)
11. Chang T.-C., Yu D., Lee Y.-S., Wentzel E. A., Arking D. E., West K. M., Dang C. V., Thomas-Tikhonenko A., Mendell J. T., Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics 2008 40 1 43 50 2-s2.0-37549008310 10.1038/ng.2007.30
12. Davis B. N., Hilyard A. C., Lagna G., SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008 454 7200 56 61 2-s2.0-46449128469 10.1038/nature07086 (Pubitemid 351931982)
13. Wulczyn F. G., Smirnova L., Rybak A., Brandt C., Kwidzinski E., Ninnemann O., Strehle M., Seiler A., Schumacher S., Nitsch R., Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB Journal 2007 21 2 415 426 2-s2.0-33846833594 10.1096/fj.06-6130com (Pubitemid 46213489)
14. Viswanathan S. R., Daley G. Q., Gregory R. I., Selective blockade of microRNA processing by Lin28. Science 2008 320 5872 97 100 2-s2.0-40849108663 10.1126/science.1154040 (Pubitemid 351490762)
15. Yang W., Chendrimada T. P., Wang Q., Higuchi M., Seeburg P. H., Shiekhattar R., Nishikura K., Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nature Structural and Molecular Biology 2006 13 1 13 21 2-s2.0-30044443191 10.1038/nsmb1041 (Pubitemid 43049397)
16. Kawahara Y., Zinshteyn B., Chendrimada T. P., Shiekhattar R., Nishikura K., RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Reports 2007 8 8 763 769 2-s2.0-34547629436 10.1038/sj.embor. 7401011 (Pubitemid 47202456)
17. Kawahara Y., Megraw M., Kreider E., Iizasa H., Valente L., Hatzigeorgiou A. G., Nishikura K., Frequency and fate of microRNA editing in human brain. Nucleic Acids Research 2008 36 16 5270 5280 2-s2.0-52649128795 10.1093/nar/gkn479
18. Tokumaru S., Suzuki M., Yamada H., let -7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008 29 11 2073 2077 2-s2.0-55549127406 10.1093/carcin/bgn187
19. Bracken C. P., Gregory P. A., Kolesnikoff N., Bert A. G., Wang J., Shannon M. F., Goodall G. J., A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Research 2008 68 19 7846 7854 2-s2.0-54049084380 10.1158/0008-5472.CAN-08-1942
20. Carew R. M., Wang B., Kantharidis P., The role of EMT in renal fibrosis. Cell and Tissue Research 2012 347 1 103 116 2-s2.0-84858308320 10.1007/s00441-011-1227-1
21. Kalluri R., Weinberg R. A., The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation 2009 119 6 1420 1428 2-s2.0-67650999875 10.1172/JCI39104
22. Zeisberg M., Bottiglio C., Kumar N., Maeshima Y., Strutz F., Müller G. A., Kalluri R., Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. American Journal of Physiology 2003 285 6 F1060 F1067 2-s2.0-0242582117 (Pubitemid 37421041)
23. López-Nouoa J. M., Nieto M. A., Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Molecular Medicine 2009 1 6-7 303 314 2-s2.0-70450142560 10.1002/emmm.200900043
24. Thiery J. P., Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer 2002 2 442 454
25. Park S.-M., Gaur A. B., Lengyel E., The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes and Development 2008 22 7 894 907 2-s2.0-41649091906 10.1101/gad.1640608 (Pubitemid 351482843)
26. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports 2008 9 6 582 589 2-s2.0-44649163918 10.1038/embor.2008.74 (Pubitemid 351772923)
27. Xia H., Ng S. S., Jiang S., Cheung W. K. C., Sze J., Bian X.-W., Kung H.-F., Lin M. C., miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochemical and Biophysical Research Communications 2010 391 1 535 541 2-s2.0-72949119530 10.1016/j.bbrc.2009.11.093
28. Kong W., Yang H., He L., Zhao J.-J., Coppola D., Dalton W. S., Cheng J. Q., MicroRNA-155 is regulated by the transforming growth factor β /Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Molecular and Cellular Biology 2008 28 22 6773 6784 2-s2.0-55849123946 10.1128/MCB.00941-08
29. Gebeshuber C. A., Zatloukal K., Martinez J., miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Reports 2009 10 4 400 405 2-s2.0-64049107465 10.1038/embor.2009.9
30. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T. T., Valastyan S., Westermann F., Speleman F., Vandesompele J., Weinberg R. A., MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biology 2010 12 3 247 256 2-s2.0-77649275464 10.1038/ncb2024
31. Du J., Yang S., An D., Hu F., Yuan W., Zhai C., Zhu T., BMP-6 inhibits microRNA-21 expression in breast cancer through repressing δ EF1 and AP-1. Cell Research 2009 19 4 487 496 2-s2.0-64149085515 10.1038/cr.2009.34
32. Zeisberg E. M., Tarnavski O., Zeisberg M., Dorfman A. L., McMullen J. R., Gustafsson E., Chandraker A., Yuan X., Pu W. T., Roberts A. B., Neilson E. G., Sayegh M. H., Izumo S., Kalluri R., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine 2007 13 8 952 961 2-s2.0-34547676391 10.1038/nm1613 (Pubitemid 47222040)
33. Kitao A., Sato Y., Sawada-Kitamura S., Harada K., Sasaki M., Morikawa H., Shiomi S., Honda M., Matsui O., Nakanuma Y., Endothelial to mesenchymal transition via transforming growth factor- β 1/smad activation is associated with portal venous stenosis in idiopathic portal hypertension. American Journal of Pathology 2009 175 2 616 626 2-s2.0-68449088473 10.2353/ajpath.2009.081061
34. Nakano Y., Oyamada M., Dai P., Nakagami T., Kinoshita S., Takamatsu T., Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Investigative Ophthalmology and Visual Science 2008 49 1 93 104 2-s2.0-39549089570 10.1167/iovs.07-0255
35. He J., Xu Y., Koya D., Hannon G. J., Role of the endothelial-to mesenchymal transition in renal fibrosis of chronic kidney disease. Clinical and Experimental Nephrology 2013 10.1007/s10157-013-0781-0
36. Li J., Bertram J. F., Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology 2010 15 5 507 512 2-s2.0-77955071008 10.1111/j.1440-1797.2010.01319.x
37. Piera-Velazquez S., Li Z., Jimenez S. A., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. American Journal of Pathology 2011 179 3 1074 1080 2-s2.0-80052851503 10.1016/j.ajpath.2011.06. 001
38. Zeisberg E. M., Potenta S. E., Sugimoto H., Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology 2008 19 12 2282 2287 2-s2.0-55249103431 10.1681/ASN.2008050513
39. Li J., Qu X., Bertram J. F., Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. American Journal of Pathology 2009 175 4 1380 1388 2-s2.0-73549092294 10.2353/ajpath.2009.090096
40. Medici D., Kalluri R., Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Seminars in Cancer Biology 2012 22 379 384 2-s2.0-84860582042 10.1016/j.semcancer.2012.04.004
41. Kumarswamy R., Volkmann I., Jazbutyte V., Dangwal S., Park D.-H., Thum T., Transforming growth factor- β -induced endothelial-to-mesenchymal transition is partly mediated by MicroRNA-21. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 2 361 369 2-s2.0-84856171521 10.1161/ATVBAHA.111.234286
42. Zhong X., Chung A. C. K., Chen H.-Y., Smad3-mediated upregulation of miR-21 promotes renal fibrosis. Journal of the American Society of Nephrology 2011 22 9 1668 1681 2-s2.0-80052316668 10.1681/ASN.2010111168
43. Lagendijk A. K., Goumans M. J., Burkhard S. B., MicroRNA-23 restricts cardiac valve formation by inhibiting has2 and extracellular hyaluronic acid production. Circulation Research 2011 109 6 649 657 2-s2.0-80052596763 10.1161/CIRCRESAHA.111.247635
44. Ghosh A. K., Nagpal V., Covington J. W., Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cellular Signalling 2012 24 5 1031 1036 2-s2.0-84857111170 10.1016/j.cellsig.2011.12.024
45. Liu C.-G., Calin G. A., Meloon B., Gamliel N., Sevignani C., Ferracin M., Dumitru C. D., Shimizu M., Zupo S., Dono M., Alder H., Bullrich F., Negrini M., Croce C. M., An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9740 9744 2-s2.0-3042752769 10.1073/pnas.0403293101 (Pubitemid 38869306)
46. Shi S., Yu L., Chiu C., Sun Y., Chen J., Khitrov G., Merkenschlager M., Holzman L. B., Zhang W., Mundel P., Bottinger E. P., Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. Journal of the American Society of Nephrology 2008 19 11 2159 2169 2-s2.0-55749112141 10.1681/ASN.2008030312
47. Duisters R. F., Tijsen A. J., Schroen B., Leenders J. J., Lentink V., Van Der Made I., Herias V., Van Leeuwen R. E., Schellings M. W., Barenbrug P., Maessen J. G., Heymans S., Pinto Y. M., Creemers E. E., MiR-133 and miR-30 Regulate connective tissue growth factor: implications for a role of micrornas in myocardial matrix remodeling. Circulation Research 2009 104 2 170 178 2-s2.0-59849128881 10.1161/CIRCRESAHA.108.182535
48. Agrawal R., Tran U., Wessely O., The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development 2009 136 23 3927 3936 2-s2.0-70450203075 10.1242/dev.037432
49. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N. M., Perera R. J., Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Research 2004 32 22 e188 2-s2.0-16344383409
50. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P., The impact of microRNAs on protein output. Nature 2008 455 7209 64 71 2-s2.0-49949116902 10.1038/nature07242
51. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J. J., Natarajan R., MicroRNA-192 in diabetic kidney glomeruli and its function in TGF- β -induced collagen expression via inhibition of E-box repressors. Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3432 3437 2-s2.0-33847682663 10.1073/pnas.0611192104 (Pubitemid 46364176)
52. Krupa A., Jenkins R., Luo D.D., Lewis A., Phillips A., Fraser D., Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. Journal of the American Society of Nephrology 2010 21 438 447
53. Yang S., Du J., Wang Z., Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer. The International Journal of Biochemistry & Cell Biology 2009 41 853 861
54. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports 2008 9 6 582 589 2-s2.0-44649163918 10.1038/embor.2008.74 (Pubitemid 351772923)
55. Korpal M., Lee E. S., Hu G., The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Journal of Biological Chemistry 2008 283 22 14910 14914 2-s2.0-47249091921 10.1074/jbc.C800074200
56. Lanford R. E., Hildebrandt-Eriksen E. S., Petri A., Persson R., Lindow M., Munk M. E., Kauppinen S., Rum H., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010 327 5962 198 201 2-s2.0-74249112787 10.1126/science.1178178
57. Trang P., Medina P. P., Wiggins J. F., Ruffino L., Kelnar K., Omotola M., Homer R., Brown D., Bader A. G., Weidhaas J. B., Slack F. J., Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010 29 11 1580 1587 2-s2.0-77949658280 10.1038/onc.2009.445
58. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S., Wiggins J. F., Bader A. G., Fagin R., Brown D., Tang D. G., The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine 2011 17 2 211 216 2-s2.0-79751473114 10.1038/nm.2284
59. Thomson J. M., Newman M., Parker J. S., Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes and Development 2006 20 16 2202 2207 2-s2.0-33747334621 10.1101/gad.1444406
60. Wynn T. A., Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. Journal of Clinical Investigation 2007 117 3 524 529 2-s2.0-33847350691 10.1172/JCI31487 (Pubitemid 46348506)